The Chosun Ilbo on MSN
NVIDIA, Eli Lilly collaborate on physical AI drug development
On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...
The world's largest and most successful trade fair for Laboratory Technology, Analysis and Biotechnology, analytica takes ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...
Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...
Kincell Bio, a contract development and manufacturing organization (CDMO), has promoted three executives to strengthen its ...
Digital Silk, a digital agency focused on branding, custom web design, and digital marketing, has published a new analysis examining how organizations source content ideas directly from customer ...
DUBLIN-- (BUSINESS WIRE)--January 13, 2026-- The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030" report has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results